OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that its international partner for Tarceva (erlotinib), Roche, informed OSI that the European ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE